We are live on ! Find out more
ANVS icon

Annovis Bio

53 hedge funds and large institutions have $14.7M invested in Annovis Bio in 2025 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 17 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

750% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 2

250% more capital invested

Capital invested by funds: $4.19M → $14.7M (+$10.5M)

162% more call options, than puts

Call options by funds: $2.01M | Put options by funds: $768K

150% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 8

26% more funds holding

Funds holding: 4253 (+11)

5.6% more ownership

Funds ownership: 10.39%15.99% (+5.6%)

Holders
53
Holders Change
+11
Holders Change %
+26.19%
% of All Funds
0.64%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
20
Increased
17
Reduced
2
Closed
8
Calls
$2.01M
Puts
$768K
Net Calls
+$1.24M
Net Calls Change
+$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
GRP
51
Global Retirement Partners
California
$346 +$301 +100 New
Citigroup
52
Citigroup
New York
$3 +$3 +1 New
Citadel Advisors
53
Citadel Advisors
Florida
-$524K -174,345 Closed
HF
54
HRT Financial
New York
-$77K -37,579 Closed
XT
55
XTX Topco
Cayman Islands
-$59.7K -28,854 Closed
TSS
56
Two Sigma Securities
New York
-$21.8K -10,511 Closed
Simplex Trading
57
Simplex Trading
Illinois
-$12.3K -4,091 Closed
SPIA
58
Steward Partners Investment Advisory
New York
-$2.07K -1,000 Closed
BF
59
BOK Financial
Oklahoma
-$1.15K -555 Closed
RA
60
Rise Advisors
New York
-$689 -333 Closed
AW
61
Avion Wealth
Texas
+$688 +229 New

ANVS Hedge Fund Activity: Q4 2025 in Review

53 of the 8,224 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q4 2025, worth a combined $14.7M — up 250% from $4.19M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new ANVS positions and 8 closed out — a net gain of 12 holders — while 17 added to existing stakes and 2 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $2.18M. The largest seller was Citadel Advisors, exiting entirely with an estimated $524K sold.

  • 53 institutional investors held Annovis Bio (ANVS) as of Q4 2025, up from 42 in Q3 2025.
  • Funds reported $14.7M of Annovis Bio stock for Q4 2025, up 250% quarter-over-quarter.
  • 20 funds opened new Annovis Bio positions in Q4 2025 and 8 closed out, a net change of +12 holders.
  • The largest Annovis Bio buyer in Q4 2025 was Marshall Wace, an estimated $2.18M added.
  • The largest Annovis Bio seller in Q4 2025 was Citadel Advisors, an estimated $524K sold.

Based on aggregated 13F filings for Q4 2025.